Resources

PainCast offers a virtual library of videos, journals, articles, podcasts, and more to our members.

Fund a Fellow Members

The Impact of Covid-19 in Pain Management

Dr. Annu Navani presents the impact that Covid-19 had on patients and pain management physicians, including challenges in providing treatment under the lockdowns and during the Covid-19 patient-physician access restrictions.

Title:

The Impact of Covid-19 in Pain Management

$2.95

Faculty:

BUY $2.95
Category:

The Impact of Covid-19 in Pain Management

Published on June 07, 2022

Annu Navani, MD

Dr. Annu Navani presents the impact that Covid-19 had on patients and pain management physicians, including challenges in providing treatment under the lockdowns and during the Covid-19 patient-physician access restrictions. Dr. Navani mentions that their previous telehealth platform for mental health services allowed them to quickly expand their ability to provide medical services through telehealth. She also mentions that the Covid-19 pandemic emphasized the importance of being prepared for events where medical institutions can be shut down with short notice. Dr. Navani further explains that the telehealth platform allowed the physicians and staff to quickly adapt to the restrictions and continue to offer high-quality pain management care.

Description

Annu Navani, MD

Dr. Annu Navani presents the impact that Covid-19 had on patients and pain management physicians, including challenges in providing treatment under the lockdowns and during the Covid-19 patient-physician access restrictions. Dr. Navani mentions that their previous telehealth platform for mental health services allowed them to quickly expand their ability to provide medical services through telehealth. She also mentions that the Covid-19 pandemic emphasized the importance of being prepared for events where medical institutions can be shut down with short notice. Dr. Navani further explains that the telehealth platform allowed the physicians and staff to quickly adapt to the restrictions and continue to offer high-quality pain management care.

Reviews

There are no reviews yet.

Be the first to review “The Impact of Covid-19 in Pain Management”

Related products

Allogenic Cell Therapy

Richard Rosenthal, MD, discusses allogenic cell therapy. The Food and Drug Administration (FDA) has not approved the injection of live cells in patients due to concerns about transmission or disease and uncontrolled cell growth. Instead, acellular methods such as injecting amniotic fluid or exosomes produced by mesenchymal stem cells can be used. These fluids come from donors and contain growth factors and matrix-building proteins that have regenerative effects.

Spinal Cord Stimulation

Dr. Vallejo discusses the evolution of spinal cord stimulation (SCS) over the past ten years. This includes how the theory of its method of action has changed and new data on high frequency stimulation. He compares different SCS systems in terms of efficacy and patient compliance. He details how tonic and high frequency stimulation differ at the cellular level, detailing neurotransmitter release and “membrane integration”, and how improvements for SCS in the future will continue.

Treating Headaches

Dr. David Rosenblum discusses his approach in treating headaches. He explains the importance of identifying the type of headache before any treatment can be selected. He describes a case in which he performed a sphenopalatine ganglion block that resolved occipital and facial pain completely. He also explains how to block both the maxillary and mandibular branches of the trigeminal nerve.

A Conversation with Dr. Calodney and Dr. Chang Chien

Dr. Calodney and Dr. Chang Chien have an informative conversation over the use of regenerative medicine. They both agree that the reliance of corticosteroids in pain medicine may not be the best option for long term, chronic pain, as these continuous steroid injections can actually be catabolic to the surrounding tissues. Dr. Chang Chien talks about current research that demonstrates the efficacy of platelet rich plasma over other commonly used injectants for OA. Dr. Calodney discusses the pros and cons for these regenerative options for degenerative disc disease.